| 國立臺灣大學 |
2007-01 |
Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
|
Tseng, Yu-Chen; Wang, Jann-Tay; Wu, Fe-Lin Lin; Chen, Yee-Chun; Chie, Wei-Chu; Chang, Shan-Chwen |
| 臺大學術典藏 |
2022-08-19T00:20:55Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shen Y.-C.; Hsu C.-H.; Cheng A.-L.; CHIUN HSU; Lin Z.-Z.; Lu L.-C.; Shao Y.-Y. |
| 國立臺灣大學 |
2012 |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 臺大學術典藏 |
2020-04-10T12:16:10Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
YU-YUN SHAO; Lu L.-C.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:13Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; Lu L.-C.; Lin Z.-Z.; Chiun Hsu; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:33Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; Lu L.-C.; Lin Z.-Z.; Hsu C.; Ying-Chun Shen; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:45Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; Lu L.-C.; ZHONG-ZHE LIN; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:53:55Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; Lu L.-C.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-03-15T07:44:49Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; LI-CHUN LU; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-06-10T06:11:07Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; Lu L.-C.; ZHONG-ZHE LIN; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺北醫學大學 |
2000 |
Prognosis of anterior crossbite.
|
林錦榮 |
| 中國醫藥大學 |
1999 |
Prognosis of esophageal squamous cell carcinoma: Analysis of clinicopathological and biological factors
|
Wang, LS; Chow, KC; Chi, KH; Liu, CC; Li, WY; Chiu, JH; Huang, MH |
| 中國醫藥大學 |
1999 |
Prognosis of esophageal squamous cell carcinoma: Analysis of clinicopathological and biological factors
|
Wang, LS; Chow, KC; Chi, KH; Liu, CC; Li, WY; Chiu, JH; Huang, MH |
| 淡江大學 |
2021-08-09 |
Prognosis of Hypoglycemia Episode in Cirrhotic Patients during Hospitalization
|
Hung, Tsung-Hsing;Tseng, Chih-Wei;Tsai, Chih-Chun;Lee, Hsing-Feng |
| 中山醫學大學 |
2016-04 |
Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan
|
HF, Chiu; MC, Chung; CJ, Chung; TM, Yu; KH, Shu; MJ, Wu |
| 臺大學術典藏 |
2021-04-29T06:43:20Z |
Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
|
Wei, Ling-Ying; Kok, Sang-Heng; Lee, Yen-Ching; WEI-YIH CHIU; Wang, Jai-Jen; Cheng, Shih-Jung; Chang, Hao-Hueng; Lee, Jang-Jaer |
| 臺大學術典藏 |
2021-07-06T04:08:41Z |
Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
|
Wei L.-Y.; SANG-HENG KOK; Lee Y.-C.; Chiu W.-Y.; Wang J.-J.; Cheng S.-J.; Chang H.-H.; Lee J.-J. |
| 臺大學術典藏 |
2021-07-07T01:46:44Z |
Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
|
Wei L.-Y.; Kok S.-H.; Lee Y.-C.; Chiu W.-Y.; Wang J.-J.; Cheng S.-J.; Chang H.-H.; JANG-JAER LEE |
| 臺大學術典藏 |
2021-07-07T03:41:10Z |
Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
|
Wei L.-Y.; Kok S.-H.; Lee Y.-C.; Chiu W.-Y.; Wang J.-J.; SHIH-JUNG CHENG; Chang H.-H.; Lee J.-J. |
| 臺大學術典藏 |
2021-10-12T03:36:26Z |
Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
|
Wei, Ling-Ying; Kok, Sang-Heng; Lee, Yen-Ching; WEI-YIH CHIU; Wang, Jai-Jen; Cheng, Shih-Jung; Chang, Hao-Hueng; Lee, Jang-Jaer |
| 臺大學術典藏 |
2021-07-06T04:08:40Z |
Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients
|
Wei L.-Y.; SANG-HENG KOK; Lee Y.-C.; Chiu W.-Y.; Wang J.-J.; Cheng S.-J.; Chang H.-H.; Lee J.-J. |
| 臺大學術典藏 |
2021-07-07T01:46:44Z |
Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients
|
Wei L.-Y.; Kok S.-H.; Lee Y.-C.; Chiu W.-Y.; Wang J.-J.; Cheng S.-J.; Chang H.-H.; JANG-JAER LEE |
| 臺大學術典藏 |
2021-07-07T03:41:09Z |
Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients
|
Wei L.-Y.; Kok S.-H.; Lee Y.-C.; Chiu W.-Y.; Wang J.-J.; SHIH-JUNG CHENG; Chang H.-H.; Lee J.-J. |
| 臺大學術典藏 |
2021-07-15T05:32:26Z |
Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients
|
Wei, Ling Ying; SANG-HENG KOK; Lee, Yen Ching; WEI-YIH CHIU; Wang, Jai Jen; SHIH-JUNG CHENG; Chang, Hao Hueng; JANG-JAER LEE |
| 臺大學術典藏 |
2022-06-27T02:14:46Z |
Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients
|
Wei, Ling-Ying; Kok, Sang-Heng; Lee, Yen-Ching; WEI-YIH CHIU; Wang, Jai-Jen; Cheng, Shih-Jung; Chang, Hao-Hueng; Lee, Jang-Jaer |
